文献速递头颈技术与安全PETCTMR

长期监测影像能否改善根治性治疗后的头颈部鳞状细胞癌患者生存:当前证据的系统综述

Does Long-Term Surveillance Imaging Improve Survival in Patients Treated for Head and Neck Squamous Cell Carcinoma? A Systematic Review of the Current Evidence.
PubMed 文献 · AJNR Am J Neuroradiol · 2025-01-08

该系统综述检索2003至2024年文献,评估治疗结束6个月后长期监测影像对根治性治疗的头颈部鳞状细胞癌患者生存的影响。共筛选718篇摘要、95篇全文,仅2篇回顾性双组研究符合纳入标准,偏倚风险均为中等。两研究结论不一致:一项报告FDG-PET/CT长期监测对III/IV期或口咽原发肿瘤患者有生存获益,另一项未显示生存获益;证据质量不足以得出确定结论。

要点

  • 仅2篇回顾性双组研究符合纳入标准,均评为中等偏倚风险,未发现随机前瞻性对照试验。
  • 一项研究示FDG-PET/CT长期监测对III/IV期或口咽原发肿瘤患者有生存获益,另一项未显示获益。
  • 长期监测影像缺乏标准化定义、监测方案不一且结果报告不一致,证据质量不足以得出确定结论。

核心结论

  • 关于长期监测影像对根治性治疗的头颈部鳞状细胞癌患者生存的影响,证据质量不足。

研究设计与样本

  • 系统综述,检索PubMed、EMBASE、Scopus、Cochrane中央对照试验注册库及Web of Science的2003至2024年英文文献,筛选718篇摘要、全文审阅95篇,最终纳入2篇回顾性双组研究,采用非随机干预研究偏倚风险评估工具,行定性评估而未做合并分析。

局限性

  • 可用的回顾性数据有限且异质,无法就长期监测影像对头颈部鳞状细胞癌的影响得出确定结论。
  • 长期监测缺乏统一定义,监测方案不一,结果报告不一致。
  • 纳入的2篇研究均为回顾性双组研究,偏倚风险均评为中等。
  • 两篇研究人群异质、风险特征与影像监测方案不同,结论不一致。
  • 未发现随机前瞻性对照试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Long-term posttreatment surveillance imaging algorithms for head and neck squamous cell carcinoma are not standardized due to debates over optimal surveillance strategy and efficacy. Consequently, current guidelines do not provide long-term surveillance imaging recommendations beyond 6 months.

PURPOSE: We performed a systematic review to evaluate the impact of long-term imaging surveillance (ie, imaging beyond 6 months following completion of treatment) on survival in patients treated definitively for head and neck squamous cell carcinoma.

DATA SOURCES: A search was conducted on PubMed, EMBASE, Scopus, the Cochrane Central Register of Controlled Trials, and the Web of Science for English literature published between 2003 and 2024 evaluating the impact of long-term surveillance imaging on survival in patients with head and neck squamous cell carcinoma.

STUDY SELECTION: We screened 718 abstracts and performed full-text review for 95 abstracts, with 2 articles meeting the inclusion criteria. The Risk of Bias in Non-Randomized Studies of Interventions assessment tool was used.

DATA ANALYSIS: A qualitative assessment without a pooled analysis was performed for the 2 studies meeting inclusion criteria.

DATA SYNTHESIS: No randomized prospective controlled trials were identified. Two retrospective 2-arm studies were included comparing long-term surveillance imaging with clinical surveillance and were each rated as having a moderate risk of bias. Each study included heterogeneous populations with variable risk profiles and imaging surveillance protocols. Both studies investigated the impact of long-term surveillance imaging on overall survival and came to different conclusions, with 1 study reporting a survival benefit for long-term surveillance imaging with FDG-PET/CT in patients with stage III or IV disease or an oropharyngeal primary tumor and the other study demonstrating no survival benefit.

LIMITATIONS: Limited heterogeneous retrospective data available precludes definitive conclusions on the impact of long-term surveillance imaging in head and neck squamous cell carcinoma.

CONCLUSIONS: There is insufficient quality evidence regarding the impact of long-term surveillance imaging on survival in patients treated definitively for head and neck squamous cell carcinoma. There is a lack of a standardized definition of long-term surveillance, variable surveillance protocols, and inconsistencies in results reporting, underscoring the need for a prospective multicenter registry assessing outcomes.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Wangaryattawanich P, Anzai Y, Mead-Harvey C, et al. Does Long-Term Surveillance Imaging Improve Survival in Patients Treated for Head and Neck Squamous Cell Carcinoma? A Systematic Review of the Current Evidence. AJNR Am J Neuroradiol. 2025. PMID: 38914430. doi:10.3174/ajnr.A8392

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。